XML 42 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2015
Segment Reporting [Abstract]  
Schedule of Segment Information
Three Months
Ended June 30,
Agriculture1
Electronics &
Communications
Industrial Biosciences
Nutrition & Health
Performance
Chemicals
Performance
Materials
Safety &
Protection
Other
Total
2015
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

Segment sales
$
3,218

 
$
534

 
$
288

 
$
826

 
$
1,502

 
$
1,365

 
$
925

 
$
2

 
$
8,660

Less: Transfers
—

 
6

 
3

 
—

 
28

 
27

 
1

 
—

 
65

Net sales
3,218

 
528

 
285

 
826

 
1,474

 
1,338

 
924

 
2

 
8,595

PTOI
774

2 
104

2 
49

2 
99

2 
54

2,3 
309

2 
308

2,7 
(60
)
2 
1,637

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2014
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

Segment sales
$
3,615

 
$
617

 
$
317

 
$
926

 
$
1,696

 
$
1,582

 
$
1,029

 
$
1

 
$
9,783

Less: Transfers
5

 
4

 
4

 
—

 
48

 
15

 
1

 
—

 
77

Net sales
3,610

 
613

 
313

 
926

 
1,648

 
1,567

 
1,028

 
1

 
9,706

PTOI
789

4 
21

4 
57

4 
97

4 
232

4 
665

4,5 
178

4 
(84
)
4 
1,955



Six Months
Ended June 30,
Agriculture1
Electronics &
Communications
Industrial Biosciences
Nutrition & Health
Performance
Chemicals
Performance
Materials
Safety &
Protection
Other
Total
2015
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

Segment sales
$
7,155

 
$
1,055

 
$
573

 
$
1,639

 
$
2,866

 
$
2,776

 
$
1,834

 
$
3

 
$
17,901

Less: Transfers
—

 
10

 
8

 
—

 
57

 
57

 
2

 
—

 
134

Net sales
7,155

 
1,045

 
565

 
1,639

 
2,809

 
2,719

 
1,832

 
3

 
17,767

PTOI
1,948

2,6 
189

2 
105

2 
188

2 
183

2,3 
636

2 
492

2,7 
(163
)
2,8 
3,578

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2014
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

Segment sales
$
8,009

 
$
1,197

 
$
618

 
$
1,787

 
$
3,287

 
$
3,116

 
$
1,976

 
$
2

 
$
19,992

Less: Transfers
8

 
7

 
7

 
—

 
105

 
29

 
2

 
—

 
158

Net sales
8,001

 
1,190

 
611

 
1,787

 
3,182

 
3,087

 
1,974

 
2

 
19,834

PTOI
2,231

4 
96

4 
113

4 
190

4 
438

4 
958

4,5 
353

4 
(176
)
4 
4,203



1 
As of June 30, 2015, Agriculture net assets were $10,246, an increase of $3,551 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables related to normal seasonality in the sales and cash collections cycle.
2 
Included adjustments to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to lower than estimated individual severance costs and workforce reductions achieved through non-severance programs, partially offset by identification of additional projects in certain segments. There was no impact from these adjustments to the company's interim Consolidated Income Statements. The adjustments impacted segment results for the three months ended June 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Chemicals - $2, Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.
3 
Included a $(61) restructuring charge recorded in employee separation / asset related charges, net, consisting of severance and related benefit costs in the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-separation. See Note 3 for additional information.
4 
Included a $(206) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture - $(47) , Electronics & Communications - $(68) , Industrial Biosciences - $(2) , Nutrition & Health - $(8) , Performance Chemicals - $(19) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.
5 
Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.
6 
Included $35 of insurance recoveries recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis® herbicide. See Note 10 for additional information.
7 
Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.
8 
Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.
Reconciliation to Consolidated Income Statements
 
Three Months Ended
June 30,
Six Months Ended
June 30,
 
2015
2014
2015
2014
Total segment PTOI
$
1,637

$
1,955

$
3,578

$
4,203

Non-operating pension and other postretirement employee benefit costs
(78
)
(34
)
(153
)
(64
)
Net exchange gains (losses)3
26

(109
)
90

(205
)
Corporate expenses1
(283
)
(278
)
(528
)
(495
)
Interest expense2
(127
)
(94
)
(211
)
(197
)
Income before income taxes
$
1,175

$
1,440

$
2,776

$
3,242



1 
Included transaction costs associated with the separation of the Performance Chemicals segment of $(119) and $(35) in the three months ended June 30, 2015 and 2014, respectively, and $(200) and $(51) in the six months ended June 30, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.
2 
Included transaction costs of $(20) in the three months ended June 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015. These costs were recorded in interest expense, in the company's interim Consolidated Income Statements.
3 
Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the six months ended June 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the three and six months ended June 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.